LS-P-TIDE

inhibitor of MTAP for patients with MTAP gene alterations in gastric esophageal, NSCLC and bladder cancer

Status:

Open

Trial Type:

Early Phase Trials for Multiple Cancer Types, Esophageal Cancer, Gastric Cancer, Kidney and Bladder Cancer, Lung Cancer

Contact:

Benedito Carneiro, MD

Benedito.carneiro@brownhealth.org